The latest version of Abbott's FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible people with diabetes in the UK. Abbott's wearable FreeStyle Libre 3 device ...

Investors feel optimistic about Abbott's robust strength in the Core Diagnostics business. Yet, unfavorable forex impacts are concerning.

Beta Bionics has begun life as a public company with a $204m initial public offering (IPO), significantly higher than its ...

In the past few years, some high-profile dividend stocks have reduced their payouts, much to the chagrin of investors. As ...

Medical device and healthcare company Abbott has opened a new facility in Kilkenny, which is expected to employ 800 people.

The system – which already has a breakthrough device designation from the FDA – will take the form of a small patch-like device similar to Abbott's FreeStyle Libre 3 device (pictured above ...

Healthcare costs in the U.S. continue to rise, making it difficult for millions of people to afford essential medical ...

During her time at CNET, Kim Wong-Shing loved demystifying the world of wellness to make it accessible to any reader. She was also passionate about exploring the intersections of health, history ...

Glucose monitoring without piercing the skin is a prize companies like Apple and Samsung have been aiming for. Now, Samsung ...

CGM traces added to DCCT data can predict microvascular diabetes complications similarly to glycated hemoglobin.